首页|期刊导航|中国结合医学杂志(英文版)|Isoquercitrin Improves Insulin Resistance by Inhibiting PTP1B-Regulated IRS/PI3K/AKT Signaling Pathway
中国结合医学杂志(英文版)2026,Vol.32Issue(4):340-349,10.DOI:10.1007/s11655-025-3934-6
Isoquercitrin Improves Insulin Resistance by Inhibiting PTP1B-Regulated IRS/PI3K/AKT Signaling Pathway
Isoquercitrin Improves Insulin Resistance by Inhibiting PTP1B-Regulated IRS/PI3K/AKT Signaling Pathway
摘要
关键词
insulin resistance/isoquercitrin/Chinese medicine/protein tyrosine phosphatase 1B/insulin receptor substrate/phosphatidylinositol-3-kinase/protein kinase B signal pathwayKey words
insulin resistance/isoquercitrin/Chinese medicine/protein tyrosine phosphatase 1B/insulin receptor substrate/phosphatidylinositol-3-kinase/protein kinase B signal pathway引用本文复制引用
LIU Si-yu,YU Lu-jing,ZHANG Sheng-nan,YUE Jia-kui,JIANG Guo-jun,LU Si-hua,LI Ying-jia,MENG Jun-yu,HUANG Gui-hong..Isoquercitrin Improves Insulin Resistance by Inhibiting PTP1B-Regulated IRS/PI3K/AKT Signaling Pathway[J].中国结合医学杂志(英文版),2026,32(4):340-349,10.基金项目
Supported by National Natural Science Foundation of China(No.82160701) (No.82160701)
Guangxi Natural Science Foundation(No.2025GXNSFAA069059) (No.2025GXNSFAA069059)
Medical Science Research Fund of Beijing Health Alliance Charitable Foundation(No.KM226002) (No.KM226002)
and Guilin Medical University Master's Research Project(No.GYYK2022004) (No.GYYK2022004)